AU6920398A - Medicament for preventive and therapeutic treatment of inflammatory diseas es - Google Patents

Medicament for preventive and therapeutic treatment of inflammatory diseas es

Info

Publication number
AU6920398A
AU6920398A AU69203/98A AU6920398A AU6920398A AU 6920398 A AU6920398 A AU 6920398A AU 69203/98 A AU69203/98 A AU 69203/98A AU 6920398 A AU6920398 A AU 6920398A AU 6920398 A AU6920398 A AU 6920398A
Authority
AU
Australia
Prior art keywords
diseas
preventive
medicament
inflammatory
therapeutic treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69203/98A
Inventor
Akira Matsumori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU6920398A publication Critical patent/AU6920398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AU69203/98A 1997-03-06 1998-03-05 Medicament for preventive and therapeutic treatment of inflammatory diseas es Abandoned AU6920398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-51473 1997-03-06
JP9051473A JPH10251147A (en) 1997-03-06 1997-03-06 Preventing and/or treating agent for inflammatory disease
PCT/EP1998/001240 WO1998038985A2 (en) 1997-03-06 1998-03-05 Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
AU6920398A true AU6920398A (en) 1998-09-22

Family

ID=12887931

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69203/98A Abandoned AU6920398A (en) 1997-03-06 1998-03-05 Medicament for preventive and therapeutic treatment of inflammatory diseas es

Country Status (3)

Country Link
JP (1) JPH10251147A (en)
AU (1) AU6920398A (en)
WO (1) WO1998038985A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292897A1 (en) * 2000-09-21 2002-04-02 Richard Agustin Bond Novel therapy
CA2544733A1 (en) 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA938897B (en) * 1992-12-01 1994-08-01 Smithkline Beecham Corp Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds

Also Published As

Publication number Publication date
WO1998038985A3 (en) 1998-12-23
JPH10251147A (en) 1998-09-22
WO1998038985A2 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
AU3993795A (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU5178296A (en) Induction of e-selectin for targetting therapeutic agents
AU2209697A (en) Fluorocarbons for diagnosis and treatment of articular disorders
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU6411199A (en) Angiogenically effective unit dose of fgf and method of administering
AU3891299A (en) Combination therapy for treatment of depression
HUP9802795A3 (en) Pharmaceutical compositions containing beta-adrenergic agent and anorectic agent for the treatment of corpulence
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU738923C (en) Preventive and therapeutic compositions for drug induced nephropathy and hepatopathy
AU2180097A (en) Composition for prevention and treatment of periodontal diseases
AU9016898A (en) Methods and compositions for treatment of restenosis
AU3046897A (en) Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
AU1331399A (en) Preparation for prevention and healing of inflammation affections
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
HUP9900147A2 (en) Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
PL321630A1 (en) Application of melantonine for treting patients suffering from drug dependence
AU3263795A (en) Medicament for treatment or prophylaxis of incontinence
EP0855387A4 (en) 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
AU3607597A (en) Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
AU6920398A (en) Medicament for preventive and therapeutic treatment of inflammatory diseas es
AU5528299A (en) Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)